medication adherence

By Aditi Pai 04:19 pm April 15, 2016
Redwood City, California-based digital medicine company Proteus Digital Health has raised $50 million from undisclosed investors. The company’s existing investors include Medtronic, Itochu, St. Jude Medical, and Kaiser Permanente Ventures. This brings the company’s total funding to at least $450 million. The Proteus digital medicine platform, called Proteus Discover, is a medication management...
By MHN Staff 02:45 pm April 14, 2016
As we do every quarter, MobiHealthNews has rounded up our Q1 2016 coverage into a handful of longform stories. This section is on pharma. Skip ahead using these links to read Q1 digital health news roundups about providers, payers, M&A and funding. Novartis Novartis announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler...
By MHN Staff 10:28 am April 8, 2016
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...
By Brian Dolan 11:54 am April 4, 2016
Proteus Digital Health announced interim study results from a randomized control study of its Proteus Discover timed with the American College of Cardiology event, ACC.16, in Chicago this week. The study included 96 patients with uncontrolled hypertension and type 2 diabetes and showed that a majority of the patients using the digital offering achieved the blood pressure target at week four. The...
By Aditi Pai 12:06 pm February 9, 2016
Dublin-based medication adherence company HealthBeacon raised $1.13 million (1 million euros) in seed funding from the Irish government through Enterprise Ireland as well as private medical and technology angel investors. The company’s offering is a sharps container that people who take injectable medications can use to discard their needles. HealthBeacon cofounder Jim Joyce told MobiHealthNews...
By Aditi Pai 10:56 am January 18, 2016
UK-based Babylon, a remote care company, has raised $25 million in a round led by Investment AB Kinnevik with participation from Hoxton Ventures, Innocent Drinks cofounders Richard Reed, Adam Balon, and Jon Wright, as well as Deepmind cofounders Demis Hassabis and Mustafa Suleyman. The company’s CEO and founder, Ali Parsa, began working on Babylon in 2013 and launched the offering in early 2105...
By Jonah Comstock 03:39 pm January 12, 2016
There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps. There’s something of a trade-off between hardware offerings, which provide real validation and accountability but can be expensive to deploy and scale, and software offerings, which are very easy to scale, but have a...
By Jonah Comstock 02:45 pm January 11, 2016
Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.  Israel-based patent authors Asaf Zomet and Michael Shynar describe the patented invention as one that uses some mechanism to detect when the user is eating, confirms that this is the case, and then delivers “a reminder to...
By Jonah Comstock 10:36 am January 11, 2016
Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients. The company says this is the first time its technology has been implemented outside of a clinical trial setting in the US. Barton Health, a health system in Lake Tahoe, California, will use the medication...
By Jonah Comstock 10:42 am October 28, 2015
AdhereTech, the New York City-based smart pill bottle company, has begun shipping the generation 2 version of its bottle to pharma and provider customers. The new version incorporates a number of changes based on user feedback that make it more robust, easier to use, and expand the reach of the company outside the United States. AdhereTech raised $1.75 million to develop the new bottle last year...